Cargando…
Identification and characterization of novel ACD variants: modulation of TPP1 protein level offsets the impact of germline loss-of-function variants on telomere length
Telomere biology disorders, largely characterized by telomere lengths below the first centile for age, are caused by variants in genes associated with telomere replication, structure, or function. One of these genes, ACD, which encodes the shelterin protein TPP1, is associated with both autosomal do...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903889/ https://www.ncbi.nlm.nih.gov/pubmed/33446513 http://dx.doi.org/10.1101/mcs.a005454 |
_version_ | 1783654822860292096 |
---|---|
author | Henslee, Gabrielle Williams, Christopher L. Liu, Pengfei Bertuch, Alison A. |
author_facet | Henslee, Gabrielle Williams, Christopher L. Liu, Pengfei Bertuch, Alison A. |
author_sort | Henslee, Gabrielle |
collection | PubMed |
description | Telomere biology disorders, largely characterized by telomere lengths below the first centile for age, are caused by variants in genes associated with telomere replication, structure, or function. One of these genes, ACD, which encodes the shelterin protein TPP1, is associated with both autosomal dominantly and autosomal recessively inherited telomere biology disorders. TPP1 recruits telomerase to telomeres and stimulates telomerase processivity. Several studies probing the effect of various synthetic or patient-derived variants have mapped specific residues and regions of TPP1 that are important for interaction with TERT, the catalytic component of telomerase. However, these studies have come to differing conclusions regarding ACD haploinsufficiency. Here, we report a proband with compound heterozygous novel variants in ACD (NM_001082486.1)—c.505_507delGAG, p.(Glu169del); and c.619delG, p.(Asp207Thrfs*22)—and a second proband with a heterozygous chromosomal deletion encompassing ACD: arr[hg19] 16q22.1(67,628,846-67,813,408)x1. Clinical data, including symptoms and telomere length within the pedigrees, suggested that loss of one ACD allele was insufficient to induce telomere shortening or confer clinical features. Further analyses of lymphoblastoid cell lines showed decreased nascent ACD RNA and steady-state mRNA, but normal TPP1 protein levels, in cells containing heterozygous ACD c.619delG, p.(Asp207Thrfs*22), or the ACD-encompassing chromosomal deletion compared to controls. Based on our results, we conclude that cells are able to compensate for loss of one ACD allele by activating a mechanism to maintain TPP1 protein levels, thus maintaining normal telomere length. |
format | Online Article Text |
id | pubmed-7903889 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cold Spring Harbor Laboratory Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-79038892021-03-09 Identification and characterization of novel ACD variants: modulation of TPP1 protein level offsets the impact of germline loss-of-function variants on telomere length Henslee, Gabrielle Williams, Christopher L. Liu, Pengfei Bertuch, Alison A. Cold Spring Harb Mol Case Stud Research Article Telomere biology disorders, largely characterized by telomere lengths below the first centile for age, are caused by variants in genes associated with telomere replication, structure, or function. One of these genes, ACD, which encodes the shelterin protein TPP1, is associated with both autosomal dominantly and autosomal recessively inherited telomere biology disorders. TPP1 recruits telomerase to telomeres and stimulates telomerase processivity. Several studies probing the effect of various synthetic or patient-derived variants have mapped specific residues and regions of TPP1 that are important for interaction with TERT, the catalytic component of telomerase. However, these studies have come to differing conclusions regarding ACD haploinsufficiency. Here, we report a proband with compound heterozygous novel variants in ACD (NM_001082486.1)—c.505_507delGAG, p.(Glu169del); and c.619delG, p.(Asp207Thrfs*22)—and a second proband with a heterozygous chromosomal deletion encompassing ACD: arr[hg19] 16q22.1(67,628,846-67,813,408)x1. Clinical data, including symptoms and telomere length within the pedigrees, suggested that loss of one ACD allele was insufficient to induce telomere shortening or confer clinical features. Further analyses of lymphoblastoid cell lines showed decreased nascent ACD RNA and steady-state mRNA, but normal TPP1 protein levels, in cells containing heterozygous ACD c.619delG, p.(Asp207Thrfs*22), or the ACD-encompassing chromosomal deletion compared to controls. Based on our results, we conclude that cells are able to compensate for loss of one ACD allele by activating a mechanism to maintain TPP1 protein levels, thus maintaining normal telomere length. Cold Spring Harbor Laboratory Press 2021-02 /pmc/articles/PMC7903889/ /pubmed/33446513 http://dx.doi.org/10.1101/mcs.a005454 Text en © 2021 Henslee et al.; Published by Cold Spring Harbor Laboratory Press http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/) , which permits reuse and redistribution, except for commercial purposes, provided that the original author and source are credited. |
spellingShingle | Research Article Henslee, Gabrielle Williams, Christopher L. Liu, Pengfei Bertuch, Alison A. Identification and characterization of novel ACD variants: modulation of TPP1 protein level offsets the impact of germline loss-of-function variants on telomere length |
title | Identification and characterization of novel ACD variants: modulation of TPP1 protein level offsets the impact of germline loss-of-function variants on telomere length |
title_full | Identification and characterization of novel ACD variants: modulation of TPP1 protein level offsets the impact of germline loss-of-function variants on telomere length |
title_fullStr | Identification and characterization of novel ACD variants: modulation of TPP1 protein level offsets the impact of germline loss-of-function variants on telomere length |
title_full_unstemmed | Identification and characterization of novel ACD variants: modulation of TPP1 protein level offsets the impact of germline loss-of-function variants on telomere length |
title_short | Identification and characterization of novel ACD variants: modulation of TPP1 protein level offsets the impact of germline loss-of-function variants on telomere length |
title_sort | identification and characterization of novel acd variants: modulation of tpp1 protein level offsets the impact of germline loss-of-function variants on telomere length |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903889/ https://www.ncbi.nlm.nih.gov/pubmed/33446513 http://dx.doi.org/10.1101/mcs.a005454 |
work_keys_str_mv | AT hensleegabrielle identificationandcharacterizationofnovelacdvariantsmodulationoftpp1proteinleveloffsetstheimpactofgermlinelossoffunctionvariantsontelomerelength AT williamschristopherl identificationandcharacterizationofnovelacdvariantsmodulationoftpp1proteinleveloffsetstheimpactofgermlinelossoffunctionvariantsontelomerelength AT liupengfei identificationandcharacterizationofnovelacdvariantsmodulationoftpp1proteinleveloffsetstheimpactofgermlinelossoffunctionvariantsontelomerelength AT bertuchalisona identificationandcharacterizationofnovelacdvariantsmodulationoftpp1proteinleveloffsetstheimpactofgermlinelossoffunctionvariantsontelomerelength |